Australia, Aug. 6 -- Epi Labs Inc., owns the trademark (2653040) for 'GENERAL CONTROL' till April 6, 2036.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, respiratory, cardiovascular, oncological, hepatological, ophthalmic, neurological, genetic, and immune system-related diseases.], 42 [Research and development in the field of biotechnology; research and development for the pharmaceutical industry.], 05 [Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, respiratory, cardiovascular, oncological, hepatological, ophthalmic, neurological, genetic, and immune system-related diseases] and 42 [Research and development in the field of biotechnology; research and development for the pharmaceutical industry]
Type of Mark: Word
Date of Acceptance: May 29
Registration Advertised: Aug. 5
For further details contact Beth M. Goldman Orrick, Herrington & Sutcliffe LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2653040.
Disclaimer: Curated by HT Syndication.
